Amy Forrestel is a Dermatology physician affiliated with Hospital of the University of Pennsylvania. OpenAlex indexes 29 publications with 551 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
23.7%Interleukin-4 Receptor alpha Antagonist13.6%Dupixent Pen100%Part D<11 patientsCorticosteroid10.1%Triamcinolone Acetonide100%Part D≥21 patientsAnti-infectives
22.9%Azole Antifungal19.4%Ketoconazole100%Part D≥30 patientsLincosamide Antibacterial3.5%Clindamycin Phosphate100%Part D<11 patientsCancer & immunology
19.9%Calcineurin inhibitor8.1%Tacrolimus100%Part D≥21 patientsPhosphodiesterase 4 Inhibitor6.3%Otezla100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Migrant skin health: perspectives from the Migrant Health Summit, Malta, 2022
British Journal of Dermatology
2023 - Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome
Journal of Clinical Investigation
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Mohamed Gad, MD, MPH
Hospital of the University of Pennsylvania
Trinity Bivalacqua, MD
Hospital of the University of Pennsylvania
Selina Luger, MD
Hospital of the University of Pennsylvania
Ian Frank, MD
Hospital of the University of Pennsylvania
Robert Modlin, MD
University of California, Los Angeles
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Joel Gelfand, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”